3304 Metabolic activity in metastatic melanoma after long-term treatment with anti-PD-1 antibodies

Benjamin Y. Kong; Catherine L. Saunders; Elizabeth Liniker; Sangeetha Ramanujam; Alex Guminski; Richard A Scolyer; Richard Kefford; Anna Menzies; Georgina V. Long; Matteo S. Carlino

doi:10.1016/s0959-8049(16)31823-8

Related publications

Article2021

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma

Sagun Parakh, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Connie S.N. Li Wai Suen, Candani Tutuka, Matteo S. Carlino, Alexander M. Menzies, Richard A Scolyer, Jonathan Cebon, Alexander Dobrovic, Georgina V. Long, Oliver Klein, Andreas Behren

Letter2021

Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma – Authors' reply

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers, Allison Betof Warner, James R. Patrinely, Patricio Serra-Bellver, Clara Allayous, Joanna Mangana, Lisa Zimmer, Claudia Trojaniello, Oliver Klein, Camille L. Gérard, Olivier Michielin, Andrew Haydon, Paolo A. Ascierto, Matteo S. Carlino, Célèste Lebbé, Paul Lorigan, Douglas B. Johnson, Shahneen Sandhu, Serigne Lo, Alexander M. Menzies, Georgina V. Long

Article2022

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Angela Pizzolla, Simon P. Keam, Ismael A. Vergara, Franco Caramia, Niko Thio, Minyu Wang, Nikolce Kocovski, Daniela Tantalo, Jafar S. Jabbari, George Au‐Yeung, Shahneen Sandhu, David Gyorki, Alison M. Weppler, Maurizio Perdicchio, Grant A. McArthur, Anthony T. Papenfuss, Paul J. Neeson

Article2017

Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy.

Tuba N. Gide, Camelia Quek, Jason Madore, Alexander M. Menzies, Rebecca Dent, Matteo S. Carlino, Alex Guminski, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Article2021

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers, Alison M. Weppler, Allison Betof Warner, James R. Patrinely, Patricio Serra-Bellver, Clara Allayous, Joanna Mangana, Khang Nguyen, Lisa Zimmer, Claudia Trojaniello, Dan Stout, Megan Lyle, Oliver Klein, Camille L. Gérard, Olivier Michielin, Andrew Haydon, Paolo A. Ascierto, Matteo S. Carlino, Célèste Lebbé, Paul Lorigan,